F.‐A. Wiesel - Concepedia

Author

F.‐A. Wiesel

Also Known As

F A Wiesel, F WIESEL, F Wiesel, F. -A. Wiesel, F. A. Wiesel, F. Wiesel, F. ‐A. Wiesel, F.-A. WIESEL, F.-A. Wiesel, F.A. Wiesel

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Uppsala University Hospital Danderyds sjukhus Lund University

About

F.‐A. Wiesel is an author at Karolinska Institutet specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	1.8K
2	Social Sciences	16	16	1.4K
3	Health Sciences	4	4	159
4	Biochemistry	2	2	96
5	Engineering	1	1	42

F.‐A. Wiesel

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics Lars Farde, F.‐A. Wiesel, A. L. Nordstr�m, Psychopharmacology PsychiatryNeurophysiologyNeuroanatomyD2-dopamine Receptor OccupancyPsychotropic Medication	1989	325
Computed tomography of the brain in patients with acute psychosis and in healthy volunteers Henrik Nybäck, F.‐A. Wiesel, Britt-Marie Berggren, Acta Psychiatrica Scandinavica	1982	148
Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients Per Karlsson, Lars Farde, C. Härnryd, Psychopharmacology Ill Schizophrenic PatientsPsychiatryPsychotic DisorderMedicinePsychotropic Medication	1995	147
Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates F.‐A. Wiesel, Gustav Wik, I Sjögren, Acta Psychiatrica Scandinavica Metabolic RateNeuropsychologyPet-mriPsychopharmacologyNeuropsychiatry	1987	124
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET Lars Farde, F.‐A. Wiesel, Paul Jansson, Psychopharmacology Acute SchizophreniaPsychiatryPsychotic DisorderMedicineD2-dopamine Receptor Occupancy	1988	112
The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects F.‐A. Wiesel, Gunnel Alfredsson, M. Ehrnebo, European Journal of Clinical Pharmacology Pharmacological StudyPharmacologyClinical PharmacologyToxicologyPharmacotherapy	1980	109
Microfluorimetric quantitation of catecholamine fluorescence in rat median eminence. II. Turnover changes in hormonal states. Anders Löfström, G. Jönsson, F.‐A. Wiesel, Journal of Histochemistry & Cytochemistry NeurotransmitterCatecholamine Nerve TerminalsExperimental PharmacologySocial SciencesNeuroendocrine Mechanism	1976	105
Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with Chlorpromazine C. Härnryd, L. Bjerkenstedt, Kerstin Björk, Acta Psychiatrica Scandinavica Schizophrenic PatientsNeuropsychologyPsychotropic MedicationPsychopharmacologyPharmacotherapy	1984	78
PET determination of regional cerebral glucose metabolism in alcohol‐dependent men and healthy controls using <sup>11</sup>C‐glucose Gustav Wik, Stefan Borg, I Sjögren, Acta Psychiatrica Scandinavica	1988	76
Amino Acids in Plasma and CSF and Monoamine Metabolites in CSF: Interrelationship in Healthy Subjects Lars Hagenfeldt, L. Bjerkenstedt, Gunnar Edman, Journal of Neurochemistry Amino AcidsHealthy SubjectsCsf LevelsCerebrospinal FluidMonoamine Metabolites	1984	73

Page 1